HIV pretreatment drug resistance trends in three geographic areas of Mexico

Pretreatment drug resistance (PDR) levels to NNRTI approaching 10% have recently been reported in Mexico. However, subnational differences may exist in PDR prevalence and transmission dynamics. We longitudinally assessed HIV PDR in three geographic areas of Mexico. HIV-infected, antiretroviral-naive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 2017-11, Vol.72 (11), p.3149-3158
Hauptverfasser: García-Morales, Claudia, Tapia-Trejo, Daniela, Quiroz-Morales, Verónica S, Navarro-Álvarez, Samuel, Barrera-Arellano, Carlos A, Casillas-Rodríguez, Jesús, Romero-Mora, Karla A, Gómez-Palacio-Schjetnan, María, Murakami-Ogasawara, Akio, Ávila-Ríos, Santiago, Reyes-Terán, Gustavo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pretreatment drug resistance (PDR) levels to NNRTI approaching 10% have recently been reported in Mexico. However, subnational differences may exist in PDR prevalence and transmission dynamics. We longitudinally assessed HIV PDR in three geographic areas of Mexico. HIV-infected, antiretroviral-naive individuals were recruited from 2008 to 2016, from the Central Metropolitan Zone (CMZ), Cancun and Tijuana (1194, 773 and 668 respectively). PDR was estimated using the Stanford HIVdb tool from plasma HIV pol sequences. A higher proportion of females, lower education and lower employment rate were observed in Tijuana, while a higher proportion of MSM was observed in the CMZ (P 
ISSN:0305-7453
1460-2091
DOI:10.1093/jac/dkx281